Selected research
Industry Research
Typhoid Vaccine Industry Research Report 2026
Market perspective
The global Typhoid Vaccine market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Typhoid Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Typhoid Vaccine is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Typhoid Vaccine is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Typhoid Vaccine include Actiza Pharmaceutical, Bharat Biotec, Merit Pharmaceuticals, PaxVax, GlaxoSmithKline, Merck and Sanofi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Typhoid Vaccine market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Typhoid Vaccine Market by Company
Actiza Pharmaceutical
Bharat Biotec
Merit Pharmaceuticals
PaxVax
GlaxoSmithKline
Merck
Sanofi
Typhoid Vaccine Segment by Type
Oral Type Typhoid Vaccine
Injection Type Typhoid Vaccine
Typhoid Vaccine Segment by Application
Pharmaceutical & Biotechnology Companies
Hospital
Research & Academic Laboratories
Others
Typhoid Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Typhoid Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Typhoid Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Typhoid Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Typhoid Vaccine manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Typhoid Vaccine by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Typhoid Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Oral Type Typhoid Vaccine
- Injection Type Typhoid Vaccine
Applications
- Pharmaceutical & Biotechnology Companies
- Hospital
- Research & Academic Laboratories
- Others
Companies covered
- Actiza Pharmaceutical
- Bharat Biotec
- Merit Pharmaceuticals
- PaxVax
- GlaxoSmithKline
- Merck
- Sanofi
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Typhoid Vaccine Market Size (2021-2032)
- 2.2.2 Global Typhoid Vaccine Sales (2021-2032)
- 2.2.3 Global Typhoid Vaccine Market Average Price (2021-2032)
- 2.3 Typhoid Vaccine by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Oral Type Typhoid Vaccine
- 2.3.3 Injection Type Typhoid Vaccine
- 2.4 Typhoid Vaccine by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical & Biotechnology Companies
- 2.4.3 Hospital
- 2.4.4 Research & Academic Laboratories
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Typhoid Vaccine Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Typhoid Vaccine Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Typhoid Vaccine Revenue of Manufacturers (2021-2026)
- 3.4 Global Typhoid Vaccine Average Price by Manufacturers (2021-2026)
- 3.5 Global Typhoid Vaccine Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Typhoid Vaccine, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Typhoid Vaccine, Product Type & Application
- 3.8 Global Manufacturers of Typhoid Vaccine, Established Date
- 3.9 Global Typhoid Vaccine Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Actiza Pharmaceutical
- 4.1.1 Actiza Pharmaceutical Company Information
- 4.1.2 Actiza Pharmaceutical Business Overview
- 4.1.3 Actiza Pharmaceutical Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Actiza Pharmaceutical Typhoid Vaccine Product Portfolio
- 4.1.5 Actiza Pharmaceutical Recent Developments
- 4.2 Bharat Biotec
- 4.2.1 Bharat Biotec Company Information
- 4.2.2 Bharat Biotec Business Overview
- 4.2.3 Bharat Biotec Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Bharat Biotec Typhoid Vaccine Product Portfolio
- 4.2.5 Bharat Biotec Recent Developments
- 4.3 Merit Pharmaceuticals
- 4.3.1 Merit Pharmaceuticals Company Information
- 4.3.2 Merit Pharmaceuticals Business Overview
- 4.3.3 Merit Pharmaceuticals Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Merit Pharmaceuticals Typhoid Vaccine Product Portfolio
- 4.3.5 Merit Pharmaceuticals Recent Developments
- 4.4 PaxVax
- 4.4.1 PaxVax Company Information
- 4.4.2 PaxVax Business Overview
- 4.4.3 PaxVax Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 PaxVax Typhoid Vaccine Product Portfolio
- 4.4.5 PaxVax Recent Developments
- 4.5 GlaxoSmithKline
- 4.5.1 GlaxoSmithKline Company Information
- 4.5.2 GlaxoSmithKline Business Overview
- 4.5.3 GlaxoSmithKline Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GlaxoSmithKline Typhoid Vaccine Product Portfolio
- 4.5.5 GlaxoSmithKline Recent Developments
- 4.6 Merck
- 4.6.1 Merck Company Information
- 4.6.2 Merck Business Overview
- 4.6.3 Merck Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Merck Typhoid Vaccine Product Portfolio
- 4.6.5 Merck Recent Developments
- 4.7 Sanofi
- 4.7.1 Sanofi Company Information
- 4.7.2 Sanofi Business Overview
- 4.7.3 Sanofi Typhoid Vaccine Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sanofi Typhoid Vaccine Product Portfolio
- 4.7.5 Sanofi Recent Developments
5 Global Typhoid Vaccine Market Scenario by Region
- 5.1 Global Typhoid Vaccine Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Typhoid Vaccine Sales by Region: 2021-2032
- 5.2.1 Global Typhoid Vaccine Sales by Region: 2021-2026
- 5.2.2 Global Typhoid Vaccine Sales by Region: 2027-2032
- 5.3 Global Typhoid Vaccine Revenue by Region: 2021-2032
- 5.3.1 Global Typhoid Vaccine Revenue by Region: 2021-2026
- 5.3.2 Global Typhoid Vaccine Revenue by Region: 2027-2032
- 5.4 North America Typhoid Vaccine Market Facts & Figures by Country
- 5.4.1 North America Typhoid Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Typhoid Vaccine Sales by Country (2021-2032)
- 5.4.3 North America Typhoid Vaccine Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Typhoid Vaccine Market Facts & Figures by Country
- 5.5.1 Europe Typhoid Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Typhoid Vaccine Sales by Country (2021-2032)
- 5.5.3 Europe Typhoid Vaccine Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Typhoid Vaccine Market Facts & Figures by Country
- 5.6.1 Asia Pacific Typhoid Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Typhoid Vaccine Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Typhoid Vaccine Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Typhoid Vaccine Market Facts & Figures by Country
- 5.7.1 South America Typhoid Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Typhoid Vaccine Sales by Country (2021-2032)
- 5.7.3 South America Typhoid Vaccine Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Typhoid Vaccine Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Typhoid Vaccine Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Typhoid Vaccine Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Typhoid Vaccine Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Typhoid Vaccine Sales by Type (2021-2032)
- 6.1.1 Global Typhoid Vaccine Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Typhoid Vaccine Sales Market Share by Type (2021-2032)
- 6.2 Global Typhoid Vaccine Revenue by Type (2021-2032)
- 6.2.1 Global Typhoid Vaccine Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Typhoid Vaccine Revenue Market Share by Type (2021-2032)
- 6.3 Global Typhoid Vaccine Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Typhoid Vaccine Sales by Application (2021-2032)
- 7.1.1 Global Typhoid Vaccine Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Typhoid Vaccine Sales Market Share by Application (2021-2032)
- 7.2 Global Typhoid Vaccine Revenue by Application (2021-2032)
- 7.2.1 Global Typhoid Vaccine Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Typhoid Vaccine Revenue Market Share by Application (2021-2032)
- 7.3 Global Typhoid Vaccine Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Typhoid Vaccine Value Chain Analysis
- 8.1.1 Typhoid Vaccine Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Typhoid Vaccine Production Mode & Process
- 8.2 Typhoid Vaccine Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Typhoid Vaccine Distributors
- 8.2.3 Typhoid Vaccine Customers
9 Global Typhoid Vaccine Analyzing Market Dynamics
- 9.1 Typhoid Vaccine Industry Trends
- 9.2 Typhoid Vaccine Industry Drivers
- 9.3 Typhoid Vaccine Industry Opportunities and Challenges
- 9.4 Typhoid Vaccine Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst